Vaccine Vial Monitor Market to Grow with a CAGR of 8.30% through 2028
Expansion of vaccination programs, technological
advancements, and government regulations are expected to drive the Global Vaccine
Vial Monitor Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Vaccine Vial
Monitor Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Global Vaccine Vial Monitor Market stood at
USD 205.10 million in 2022 and is anticipated to grow with a CAGR of 8.30% in
the forecast period, 2024-2028. This can be attributed to reduction of vaccine
wastage. Efforts to reduce vaccine wastage have contributed to the growth of
the VVM market. By providing visual indicators of vaccine viability, VVMs
enable healthcare workers to administer vaccines confidently, reducing the
likelihood of discarding vaccines that may still be effective. This not only
saves resources but also ensures a more equitable distribution of vaccines. Furthermore, tailored VVM solutions for specific
vaccines and regions will become more prevalent. Manufacturers will develop
VVMs that are optimized for the unique storage and distribution requirements of
different vaccines and healthcare settings.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Vaccine Vial Monitor Market”
The global market for vaccine vials is experiencing
robust growth due to several key factors. Firstly, the increasing prevalence of
infectious diseases is a significant driver, prompting a growing focus on
immunization programs and, consequently, sustaining the demand for vaccine
vials to support vaccine storage and distribution. Furthermore, ongoing
technological innovations in vial materials and design aim to enhance the
shelf-life and stability of vaccines, contributing to market expansion.
Stringent regulatory guidelines, emphasizing quality control measures and
sterility requirements, influence manufacturers to produce high-quality vials.
The rise of healthcare initiatives, such as vaccination campaigns led by
organizations like the WHO, GAVI, the Vaccine Alliance, and national health
departments of various countries, is also propelling the demand for vaccine
vials. Demographic factors, including population growth and an aging population
more susceptible to diseases, further contribute to the increasing demand.
Additionally, advancements in distribution logistics and cold chain management
are enabling more effective and extensive vaccine distribution, indirectly
bolstering the global market.
The Global Vaccine Vial Monitor Market is segmented
into type, application, regional distribution, and company
Based on its type, multi-dose vials stand out as the
dominant category in 2022. Multi-dose vials are generally recognized for their
cost-effectiveness compared to single-dose vials, primarily due to their
reduced need for packaging materials and storage space. This cost efficiency
makes them particularly appealing, especially in the context of large-scale
immunization initiatives. When there is a requirement for extensive vaccination
efforts, such as responding to a pandemic or conducting routine immunization
programs, multi-dose vials offer a means to rapidly and efficiently vaccinate a
substantial number of individuals. This is especially pertinent in
resource-constrained environments where swift administration is critical.
Based on region, North America is poised to assert
dominance in the Global Vaccine Vial Monitor Market for several compelling
reasons. Firstly, the region boasts a highly developed healthcare
infrastructure, including advanced vaccine manufacturing facilities and a
robust distribution network. This infrastructure places North America at the
forefront of vaccine production and distribution, driving the demand for
Vaccine Vial Monitors (VVMs) as a crucial tool in ensuring vaccine potency and
integrity. Additionally, stringent regulatory standards in North America
underscore the importance of maintaining temperature-sensitive vaccines within
the prescribed temperature range, further fueling the adoption of VVMs.
Furthermore, the region's proactive approach to vaccination, particularly
during public health emergencies such as pandemics, necessitates precise
temperature monitoring and control, making VVMs an indispensable component of
vaccination programs. These factors, combined with a strong focus on healthcare
innovation and a commitment to quality assurance, position North America as the
dominant force in the Global Vaccine Vial Monitor Market.
Major companies operating in Global Vaccine Vial
Monitor Market are:
- Cardinal Health Inc
- Catalent Inc
- Corning Incorporated
- DWK Life Sciences GmbH
- Elitech Technology, Inc.
- Elpro-Buchs AG
- EVIGENCE SENSORS Inc
- Gerresheimer AG
- Schott AG
- Thermo Fisher Scientific Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The upcoming trends in the Global Vaccine Vial
Monitor Market promise to reshape the landscape of vaccine quality assurance
and distribution. From smart sensors and blockchain integration to AI-driven
analytics and environmental sustainability, these trends are poised to
revolutionize the way vaccines are monitored and managed. They represent a
commitment to ensuring that vaccines remain safe, effective, and accessible to
people around the world,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Vaccine Vial Monitor Market By Type
(Multi-Dose, Single Dose), By Application (Preventive Vaccine, Therapeutic
Vaccine), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Vaccine Vial Monitor Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Vaccine Vial Monitor Market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com